Phase III KEYNOTE-204: does prior therapy impact outcomes in R/R cHL?
John Kuruvilla • 8 Dec 2020
iwNHL 2015 roundtable: Using B-cell biology to inform therapy
Kieron Dunleavy et al. • 3 Oct 2015
Will knowledge of the molecular pathology of lymphoma improve clinical trials?
David Maloney et al.